What’s New (2025)

  • A Decision Making in HIV PEP tool now supplements the guidelines, providing a summary of the information required to prescribe PEP. 
  • Removal of the “very high prevalence population (MSM who inject drugs)” category from Table 2: PEP recommendations after NON-OCCUPATIONAL exposure. 
  • Removal of the “estimated HIV acquisition risk if source is viraemic, by population group” tables in Appendix A. 
Scroll to Top